Fund shareholders of REVOLUTION MEDICINES INC
ISIN US76155X1000 · United States · LEI 549300JU3X0LBCQ65892
- Fund shareholders
- 512
- Of which ETFs
- 120 392 other funds
- Value held
- ≈ 11.1B $ 11B $ · 404.1M SEK · 677.8K €
- Share of capital
- 28.7 % of 214.3M shares on Jul 31, 2026
This issuer has other securities: REVOLUTION MEDICINES INC WTS 12/26 (US76155X1182)
512 funds hold this company. This table lists the 511 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. The “Fund reports” tab lists it, with its weight.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 6,412,413 | 1.2B $ | 0.05 % | 2.99 % | as of Jun 30, 2026 ↗ |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 4,631,150 | 867.3M $ | 0.46 % | 2.16 % | as of Jun 30, 2026 ↗ |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 2,670,853 | 500.2M $ | 1.06 % | 1.25 % | as of Jun 30, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 2,475,942 | 389.9M $ | 0.39 % | 1.16 % | as of May 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 2,291,511 | 429.2M $ | 0.44 % | 1.07 % | as of Jun 30, 2026 ↗ |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 1,988,729 | 372.9M $ | 0.98 % | 0.93 % | as of Jul 31, 2026 ↗ |
| Growth Fund of America Growth Fund of America | 1,838,422 | 289.5M $ | 0.08 % | 0.86 % | as of May 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 1,349,118 | 252.7M $ | 2.78 % | 0.63 % | as of Jun 30, 2026 ↗ |
| JPMorgan Large Cap Growth Fund JPMorgan Trust II | 1,166,558 | 218.5M $ | 0.18 % | 0.54 % | as of Jun 30, 2026 ↗ |
| iShares Russell Mid-Cap Growth ETF iShares Trust | 1,128,977 | 211.4M $ | 0.98 % | 0.53 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 1,011,551 | 159.3M $ | 0.37 % | 0.47 % | as of May 31, 2026 ↗ |
| Fidelity OTC Portfolio Fidelity Securities Fund | 1,002,878 | 188.1M $ | 0.44 % | 0.47 % | as of Jul 31, 2026 ↗ |
| Janus Henderson Enterprise Fund Janus Investment Fund | 978,312 | 183.2M $ | 0.82 % | 0.46 % | as of Jun 30, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 942,767 | 148.5M $ | 0.65 % | 0.44 % | as of May 31, 2026 ↗ |
| Janus Henderson Forty Fund Janus Investment Fund | 937,887 | 175.6M $ | 0.74 % | 0.44 % | as of Jun 30, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund Janus Investment Fund | 936,558 | 175.4M $ | 3.02 % | 0.44 % | as of Jun 30, 2026 ↗ |
| iShares Russell Mid-Cap ETF iShares Trust | 786,979 | 147.4M $ | 0.26 % | 0.37 % | as of Jun 30, 2026 ↗ |
| iShares Russell 1000 Growth ETF iShares Trust | 730,570 | 136.8M $ | 0.11 % | 0.34 % | as of Jun 30, 2026 ↗ |
| Fidelity Mid Cap Index Fund Fidelity Salem Street Trust | 724,852 | 135.9M $ | 0.26 % | 0.34 % | as of Jul 31, 2026 ↗ |
| Growth Fund AMERICAN FUNDS INSURANCE SERIES | 715,338 | 134M $ | 0.23 % | 0.33 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 690,499 | 129.3M $ | 1.20 % | 0.32 % | as of Jun 30, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 682,871 | 107.5M $ | 0.39 % | 0.32 % | as of May 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 675,072 | 106.3M $ | 2.02 % | 0.31 % | as of May 31, 2026 ↗ |
| MFS Mid Cap Growth Fund MFS Series Trust IV | 654,055 | 103M $ | 0.75 % | 0.31 % | as of May 31, 2026 ↗ |
| Lord Abbett Growth Leaders Fund LORD ABBETT SECURITIES TRUST | 613,872 | 115.1M $ | 1.55 % | 0.29 % | as of Jul 31, 2026 ↗ |
| Franklin Dynatech Fund Franklin Custodian Funds | 600,000 | 112.4M $ | 0.37 % | 0.28 % | as of Jun 30, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 576,602 | 90.8M $ | 0.37 % | 0.27 % | as of May 31, 2026 ↗ |
| Janus Henderson Triton Fund Janus Investment Fund | 563,888 | 105.6M $ | 1.78 % | 0.26 % | as of Jun 30, 2026 ↗ |
| Schwab U.S. Mid-Cap ETF SCHWAB STRATEGIC TRUST | 530,570 | 83.6M $ | 0.57 % | 0.25 % | as of May 31, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 527,759 | 98.8M $ | 0.67 % | 0.25 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 495,491 | 92.8M $ | 0.78 % | 0.23 % | as of Jun 30, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 485,701 | 76.5M $ | 0.40 % | 0.23 % | as of May 31, 2026 ↗ |
| Fidelity Contrafund Fidelity Contrafund | 477,800 | 89.5M $ | 0.05 % | 0.22 % | as of Jun 30, 2026 ↗ |
| Federated Hermes MDT Mid Cap Growth Fund Federated Hermes Equity Funds | 461,570 | 86.6M $ | 1.31 % | 0.22 % | as of Jul 31, 2026 ↗ |
| Janus Henderson Research Fund Janus Investment Fund | 412,224 | 77.2M $ | 0.26 % | 0.19 % | as of Jun 30, 2026 ↗ |
| Janus Henderson Venture Fund Janus Investment Fund | 384,421 | 72M $ | 1.99 % | 0.18 % | as of Jun 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 370,778 | 58.4M $ | 0.04 % | 0.17 % | as of May 31, 2026 ↗ |
| Janus Henderson Balanced Fund Janus Investment Fund | 362,309 | 67.9M $ | 0.24 % | 0.17 % | as of Jun 30, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 361,340 | 56.9M $ | 0.96 % | 0.17 % | as of May 29, 2026 ↗ |
| iShares MSCI USA Momentum Factor ETF iShares Trust | 352,480 | 66.1M $ | 0.26 % | 0.16 % | as of Jul 31, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 352,200 | 66M $ | 3.00 % | 0.16 % | as of Jul 31, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 350,000 | 55.1M $ | 0.95 % | 0.16 % | as of May 31, 2026 ↗ |
| Janus Henderson Contrarian Fund Janus Investment Fund | 348,053 | 65.2M $ | 1.19 % | 0.16 % | as of Jun 30, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 299,436 | 47.2M $ | 0.04 % | 0.14 % | as of May 31, 2026 ↗ |
| T. Rowe Price Mid-Cap Growth Fund, Inc. T. ROWE PRICE MID-CAP GROWTH FUND, INC. | 297,199 | 55.7M $ | 0.24 % | 0.14 % | as of Jun 30, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 258,226 | 48.4M $ | 0.05 % | 0.12 % | as of Jun 30, 2026 ↗ |
| Fidelity Large Cap Growth Index Fund Fidelity Salem Street Trust | 251,879 | 47.2M $ | 0.11 % | 0.12 % | as of Jul 31, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 240,308 | 45.1M $ | 0.09 % | 0.11 % | as of Jul 31, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 240,300 | 45.1M $ | 1.44 % | 0.11 % | as of Jul 31, 2026 ↗ |
| Columbia Cornerstone Growth Fund COLUMBIA FUNDS SERIES TRUST I | 226,688 | 42.5M $ | 0.66 % | 0.11 % | as of Jul 31, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 225,218 | 42.2M $ | 2.36 % | 0.11 % | as of Jun 30, 2026 ↗ |
| Marsico Midcap Growth Focus Fund MARSICO INVESTMENT FUND | 219,460 | 41.1M $ | 4.38 % | 0.10 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. T. ROWE PRICE DIVERSIFIED MID-CAP GROWTH FUND, INC. | 207,447 | 38.9M $ | 0.79 % | 0.10 % | as of Jun 30, 2026 ↗ |
| AP7 Aktiefond Sjunde AP-fonden | 206,123 | 191M SEK | 0.01 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Fidelity Mid Cap Growth Index Fund Fidelity Salem Street Trust | 204,762 | 38.3M $ | 0.98 % | 0.10 % | as of Jun 30, 2026 ↗ |
| Franklin Small-Mid Cap Growth Fund Franklin Strategic Series | 203,777 | 38.2M $ | 1.10 % | 0.10 % | as of Jul 31, 2026 ↗ |
| JNL/T. Rowe Price Mid-Cap Growth Fund JNL Series Trust | 185,991 | 34.8M $ | 0.80 % | 0.09 % | as of Jun 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 185,428 | 34.8M $ | 3.01 % | 0.09 % | as of Jul 31, 2026 ↗ |
| VIP Mid Cap Portfolio Variable Insurance Products Fund III | 184,200 | 34.5M $ | 0.36 % | 0.09 % | as of Jun 30, 2026 ↗ |
| Fidelity Blue Chip Growth Fund Fidelity Securities Fund | 170,500 | 32M $ | 0.03 % | 0.08 % | as of Jul 31, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 163,671 | 30.7M $ | 0.05 % | 0.08 % | as of Jul 31, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 162,218 | 30.4M $ | 0.03 % | 0.08 % | as of Jul 31, 2026 ↗ |
| VANGUARD MID-CAP GROWTH FUND VANGUARD WHITEHALL FUNDS | 159,681 | 29.9M $ | 1.11 % | 0.07 % | as of Jul 31, 2026 ↗ |
| VANGUARD GLOBAL EQUITY FUND VANGUARD HORIZON FUNDS | 156,510 | 29.3M $ | 0.39 % | 0.07 % | as of Jun 30, 2026 ↗ |
| Victory Science & Technology Fund Victory Portfolios III | 152,410 | 28.6M $ | 1.91 % | 0.07 % | as of Jul 31, 2026 ↗ |
| VIP Growth Portfolio Variable Insurance Products Fund | 141,100 | 26.4M $ | 0.21 % | 0.07 % | as of Jun 30, 2026 ↗ |
| iShares Russell 1000 ETF iShares Trust | 133,068 | 24.9M $ | 0.05 % | 0.06 % | as of Jun 30, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 127,827 | 24M $ | 0.06 % | 0.06 % | as of Jul 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 121,187 | 22.7M $ | 0.05 % | 0.06 % | as of Jul 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 120,079 | 18.9M $ | 0.07 % | 0.06 % | as of May 31, 2026 ↗ |
| Capital Group U.S. Small and Mid Cap ETF Capital Group Equity ETF Trust I | 118,517 | 18.7M $ | 0.67 % | 0.06 % | as of May 31, 2026 ↗ |
| Janus Henderson VIT Balanced Portfolio Janus Aspen Series | 118,340 | 22.2M $ | 0.24 % | 0.06 % | as of Jun 30, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 115,805 | 21.7M $ | 0.02 % | 0.05 % | as of Jun 30, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 115,782 | 18.2M $ | 0.04 % | 0.05 % | as of May 31, 2026 ↗ |
| Columbia Variable Portfolio - Cornerstone Equity Fund Columbia Funds Variable Series Trust II | 115,674 | 21.7M $ | 0.65 % | 0.05 % | as of Jun 30, 2026 ↗ |
| VANGUARD RUSSELL 1000 VALUE INDEX FUND VANGUARD SCOTTSDALE FUNDS | 114,373 | 18M $ | 0.08 % | 0.05 % | as of May 31, 2026 ↗ |
| iShares U.S. Healthcare ETF iShares Trust | 112,298 | 21.1M $ | 0.59 % | 0.05 % | as of Jul 31, 2026 ↗ |
| Large Cap Index Master Portfolio Master Investment Portfolio | 111,501 | 20.9M $ | 0.05 % | 0.05 % | as of Jun 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 111,381 | 20.9M $ | 5.27 % | 0.05 % | as of Jun 30, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 108,686 | 20.4M $ | 0.05 % | 0.05 % | as of Jul 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 108,204 | 20.3M $ | 0.03 % | 0.05 % | as of Jun 30, 2026 ↗ |
| Nuveen Large Cap Growth Index Fund TIAA-CREF Funds | 107,500 | 20.2M $ | 0.11 % | 0.05 % | as of Jul 31, 2026 ↗ |
| Columbia Variable Portfolio - Cornerstone Growth Fund Columbia Funds Variable Series Trust II | 107,255 | 20.1M $ | 0.72 % | 0.05 % | as of Jun 30, 2026 ↗ |
| VANGUARD TAX-MANAGED CAPITAL APPRECIATION FUND VANGUARD TAX-MANAGED FUNDS | 104,241 | 19.5M $ | 0.07 % | 0.05 % | as of Jun 30, 2026 ↗ |
| LORD ABBETT DEVELOPING GROWTH FUND INC LORD ABBETT DEVELOPING GROWTH FUND, INC. | 102,627 | 19.2M $ | 0.87 % | 0.05 % | as of Jul 31, 2026 ↗ |
| Invesco NASDAQ Next Gen 100 ETF Invesco Exchange-Traded Fund Trust II | 102,328 | 16.1M $ | 1.45 % | 0.05 % | as of May 31, 2026 ↗ |
| iShares U.S. Small-Cap Equity Factor ETF iShares Trust | 102,208 | 19.2M $ | 0.47 % | 0.05 % | as of Jul 31, 2026 ↗ |
| Fidelity Contrafund K6 Fidelity Contrafund | 99,833 | 18.7M $ | 0.05 % | 0.05 % | as of Jun 30, 2026 ↗ |
| Touchstone Strategic Trust-Touchstone Mid Cap Growth Fund Touchstone Strategic Trust | 99,683 | 18.7M $ | 0.82 % | 0.05 % | as of Jun 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 97,068 | 18.2M $ | 0.05 % | 0.05 % | as of Jun 30, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 95,000 | 15M $ | 0.01 % | 0.04 % | as of May 31, 2026 ↗ |
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 93,878 | 14.8M $ | 1.06 % | 0.04 % | as of May 29, 2026 ↗ |
| Janus Henderson Mid Cap Value Fund Janus Investment Fund | 93,598 | 17.5M $ | 0.87 % | 0.04 % | as of Jun 30, 2026 ↗ |
| Fidelity Balanced Fund Fidelity Puritan Trust | 92,900 | 14.6M $ | 0.02 % | 0.04 % | as of May 31, 2026 ↗ |
| Parnassus Mid Cap Growth Fund Parnassus Funds | 91,190 | 17.1M $ | 2.01 % | 0.04 % | as of Jun 30, 2026 ↗ |
| Goldman Sachs Small/Mid Cap Growth Fund Goldman Sachs Trust | 88,514 | 13.9M $ | 1.11 % | 0.04 % | as of May 31, 2026 ↗ |
| Fidelity OTC K6 Portfolio Fidelity Securities Fund | 86,500 | 16.2M $ | 0.44 % | 0.04 % | as of Jul 31, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 86,450 | 13.6M $ | 7.73 % | 0.04 % | as of May 31, 2026 ↗ |
| Mid Cap Growth Fund John Hancock Investment Trust | 86,177 | 16.1M $ | 1.20 % | 0.04 % | as of Jun 30, 2026 ↗ |
| Fidelity U.S. Equity Central Fund Fidelity Central Investment Portfolios LLC | 86,000 | 16.1M $ | 0.07 % | 0.04 % | as of Jun 30, 2026 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 2.13 % | as of Sep 30, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Tema Oncology ETF Tema ETF Trust | 7.73 % | as of May 31, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 5.27 % | as of Jun 30, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 4.94 % | as of Jul 31, 2026 ↗ |
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 4.55 % | as of Jul 31, 2026 ↗ |
| Marsico Midcap Growth Focus Fund MARSICO INVESTMENT FUND | 4.38 % | as of Jun 30, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 4.13 % | as of Mar 31, 2026 ↗ |
| Corgi Genomics & Precision Medicine ETF Corgi ETF Trust I | 3.74 % | as of Jun 30, 2026 ↗ |
| NICHOLAS PARTNERS SMALL CAP GROWTH FUND ADVISORS' INNER CIRCLE III | 3.69 % | as of Jun 30, 2026 ↗ |
| Tema Heart & Health ETF Tema ETF Trust | 3.33 % | as of May 31, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund Janus Investment Fund | 3.02 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 492 | +92 | 60,988,660 | +27.2 % |
| 2026Q2 | 400 | +41 | 47,949,343 | -6.1 % |
| 2026Q1 | 359 | +41 | 51,041,234 | -8.6 % |
| 2025Q4 | 318 | -18 | 55,857,845 | -6.5 % |
| 2025Q3 | 336 | +10 | 59,732,762 | -7.8 % |
| 2025Q2 | 326 | +4 | 64,794,405 | +3.7 % |
| 2025Q1 | 322 | +9 | 62,505,392 | +5.6 % |
| 2024Q4 | 313 | +26 | 59,209,688 | +5.5 % |
| 2024Q3 | 287 | +20 | 56,129,869 | +4.9 % |
| 2024Q2 | 267 | +18 | 53,490,879 | +17.6 % |
| 2024Q1 | 249 | +26 | 45,498,077 | +12.7 % |
| 2023Q4 | 223 | 40,365,735 |
Institutional managers
503 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 13,604,796 | 1.3B $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 11,212,706 | 1.1B $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 9,766,496 | 949.5M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 9,555,357 | 929.3M $ | as of Mar 31, 2026 |
| FMR LLC | 8,464,314 | 823.2M $ | as of Mar 31, 2026 |
| Nextech Invest, Ltd. | 7,601,087 | 739.2M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 6,655,703 | 647.3M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 6,027,819 | 586.2M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,475,611 | 532.5M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,402,662 | 428.2M $ | as of Mar 31, 2026 |
| UBS Group AG | 4,386,791 | 426.6M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,338,142 | 323.9M $ | as of Mar 31, 2026 |
| Alphabet Inc. | 3,292,525 | 320.2M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3,232,213 | 314.3K $ | as of Mar 31, 2026 |
| BVF INC/IL | 2,856,782 | 277.8M $ | as of Mar 31, 2026 |
| Casdin Capital, LLC | 2,577,333 | 250.6M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 2,506,570 | 243.8M $ | as of Mar 31, 2026 |
| Holocene Advisors, LP | 2,468,644 | 240.1M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 2,375,000 | 231M $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 2,344,444 | 228M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2,297,000 | 223.4M $ | as of Mar 31, 2026 |
| Darwin Global Management, Ltd. | 2,211,018 | 205M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,185,500 | 212.5M $ | as of Mar 31, 2026 |
| Logos Global Management LP | 2,000,000 | 194.5M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 1,885,821 | 183.4M $ | as of Mar 31, 2026 |
Declared shareholders of REVOLUTION MEDICINES INC
There are 4 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Farallon Capital Management, L.L.C. and 28 others | 6.40 % | 13,564,149 | as of Jun 30, 2026 · SCHEDULE 13G |
| BlackRock, Inc. | 5.70 % | 12,201,395 | as of Jun 30, 2026 · SCHEDULE 13G |
| Baker Bros. Advisors LP and 3 others | 5.30 % | 11,443,357 | as of Jun 30, 2026 · SCHEDULE 13G |
| JANUS HENDERSON GROUP Ltd. | 5.10 % | 10,736,145 | as of Jun 30, 2026 · SCHEDULE 13G |
Funds holding the debt of REVOLUTION MEDICINES INC
26 funds declare 26 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of REVOLUTION MEDICINES INC". https://titelia.com/en/stocks/revolution-medicines-inc-US76155X1000